Camden Property Trust
CPT
$99.31
+0.50%
Camden Property Trust is a real estate investment trust that owns, manages, develops, and redevelops multifamily apartment communities across the United States, with interests in roughly 175 properties comprising nearly 59,921 apartment homes. As one of the largest publicly traded residential REITs, Camden is a scaled institutional operator concentrated in high-growth Sun Belt and select coastal markets, giving it meaningful pricing power and operating leverage relative to smaller private landlords. The current investor debate centers on whether decelerating rental growth and elevated new-supply deliveries will pressure same-store revenue, even as the company's conservative balance sheet and buyback activity signal management confidence in intrinsic value. With the stock down roughly 7.6% over the past year and trading near the bottom of its 52-week range, the narrative has shifted from growth-at-a-premium toward valuation support, dividend durability, and the timing of a multifamily supply-demand inflection.…
CPT
Camden Property Trust
$99.31
Investment Opinion: Should I buy CPT Today?
The synthesized recommendation is Hold, with a neutral-to-cautious thesis: Camden offers a 3.86% dividend yield and 17.6% upside to the analyst average target of $116.60, but revenue growth has stalled at 0.08% YoY and the forward PE of 90.94x signals expected earnings compression. The consensus recommendation of hold with a mean of 2.58 reflects limited near-term conviction, and the stock's 10.03% YTD decline and position near the 52-week low of $96.53 suggest the market is pricing in continued fundamental weakness.
Supporting evidence for the Hold rating includes the 3.86% dividend yield, which is above the sector average and provides income support, and TTM free cash flow of $714.01 million, which better covers the distribution than the 119.89% payout ratio implies. However, the trailing PE of 31.10x and price-to-book of 2.73x are at a premium to typical REIT valuations, and the EV/EBITDA of 13.77x exceeds the 10-12x value range. Revenue growth of 0.08% YoY and flat operating income of $75.18 million versus $75.11 million a year ago highlight the lack of organic growth, while the 22.65 percentage point underperformance versus SPY over one year underscores the weak relative strength.
The biggest risks that could invalidate the thesis are a breakdown below the 52-week low of $96.53, a dividend cut if free cash flow remains negative, and a failure of multifamily supply to peak in 2026. The rating would upgrade to Buy if same-store revenue growth accelerates above 2% YoY or if the stock drops below $90, improving the risk/reward. It would downgrade to Sell if revenue growth turns negative, the dividend is cut, or the stock breaks below $96.53 with high volume. Relative to its own history and peers, Camden appears fairly valued to slightly overvalued on trailing metrics, but the forward PE of 90.94x suggests the market is pricing in a significant earnings decline that may already be reflected in the price.
Sign up to view all
CPT 12-Month Price Forecast
Camden presents a neutral risk/reward at current levels: the stock is down 10.03% YTD and near its 52-week low, with a 3.86% dividend yield and 17.6% upside to analyst targets, but revenue growth has stalled and the forward PE of 90.94x signals expected earnings compression. The low beta of 0.782 and conservative balance sheet offer defensive qualities, yet the 119.89% payout ratio and negative Q1 free cash flow raise questions about dividend sustainability. The key tension is whether the multifamily supply wave peaks in 2026, which would validate the bull case and drive the stock toward $120-132, or persists into 2027, pressuring the stock toward $85-96. I would upgrade to bullish if same-store revenue growth accelerates above 2% YoY or if the stock drops below $90 with improving fundamentals, and downgrade to bearish if the dividend is cut or revenue growth turns negative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Camden Property Trust's 12-month outlook, with a consensus price target around $116.10 and implied upside of +16.9% versus the current price.
Average Target
$116.10
0 analysts
Implied Upside
+16.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$102 - $132
Analyst target range
Camden is covered by 22 analysts with a consensus recommendation of hold and a recommendation mean of 2.58, reflecting a market that sees limited near-term upside. The average target price of $116.60 implies roughly 17.6% upside from the current price of $99.12, which is a meaningful gap for a low-beta REIT and suggests analysts believe the selloff has overshot fundamentals. However, the hold consensus means the upside is not backed by strong conviction, and the distribution of ratings is skewed toward neutral and underperform, with recent actions from Barclays (Equal Weight), Scotiabank (Sector Underperform), Morgan Stanley (Equal Weight), and Wells Fargo (Equal Weight) showing no upgrades in the visible data. The consensus is best characterized as cautiously neutral with a value tilt, not bullish. The target range spans $105.00 to $132.00, a spread of 25.7% that signals meaningful disagreement about the company's trajectory. The high target of $132.00, 33.2% above the current price, likely assumes a multifamily supply peak in 2026, accelerating rent growth into 2027, and multiple expansion back toward historical norms, while the low target of $105.00, just 5.9% above the current price, prices in continued revenue stagnation, elevated concessions, and no relief from interest expense. The fact that even the low target sits above the current price suggests analysts see the stock as undervalued, but the clustering of ratings at hold and underperform indicates that the path to those targets is uncertain. The absence of recent upgrades, combined with the wide target spread, points to low conviction and a stock that may remain range-bound until operating fundamentals show a clear inflection.
Bulls vs Bears: CPT Investment Factors
The bear case currently has stronger evidence: revenue growth has stalled at 0.08% YoY, the forward PE of 90.94x implies an earnings collapse, and the technical trend is decisively negative with the stock near its 52-week low. The bull case rests on valuation support from a 3.86% dividend yield, a low beta of 0.782, and analyst targets implying 17.6% upside, but these are passive supports rather than growth catalysts. The single most important tension is whether the multifamily supply wave peaks in 2026 and rent growth inflects higher in 2027, which would validate the bull case; if supply persists and concessions deepen, the bear case dominates. Until same-store revenue shows a clear inflection, the risk/reward remains skewed to the downside despite the stock trading near capitulation levels.
Bullish
- Analyst targets imply 17.6% upside: The 22-analyst consensus average target price of $116.60 sits 17.6% above the current $99.12, and even the lowest target of $105.00 is 5.9% higher. This suggests the selloff has overshot fundamentals, especially for a low-beta REIT with a 3.86% dividend yield.
- Dividend yield provides valuation support: The 3.86% dividend yield is above the typical residential REIT average and offers a tangible return while waiting for a multifamily supply-demand inflection. With TTM free cash flow of $714.01 million, the distribution is better covered by cash flow than the 119.89% payout ratio suggests.
- Conservative balance sheet with low beta: Debt-to-equity of 0.894 and a beta of 0.782 mean Camden carries moderate leverage and roughly 22% less volatility than the broader market. This defensive profile limits drawdown severity in rate-sensitive downturns and supports dividend durability.
- Buybacks signal management confidence: Camden repurchased $262.83 million of stock in Q1 2026, a clear signal that management views the shares as undervalued near the 52-week low of $96.53. This capital allocation reduces share count and can amplify per-share earnings recovery.
Bearish
- Revenue growth has stalled at 0.08% YoY: Q1 2026 revenue of $390.87 million grew just 0.08% versus $390.57 million in Q1 2025, and the top line has been locked in a $390-397 million band for five quarters. Without rent growth, earnings growth must come from margin expansion or capital allocation, both of which have limited runway.
- Forward PE of 90.94x signals earnings collapse: The forward PE of 90.94x is nearly three times the trailing PE of 31.10x, implying consensus expects a sharp earnings decline. This is a highly unusual and bearish signal that the stock is not cheap on forward earnings despite appearing moderately valued on trailing results.
- Payout ratio of 119.89% is unsustainable: The dividend payout ratio of 119.89% against a 3.86% yield means the distribution is not fully covered by earnings. Camden is funding dividends and buybacks partly through balance sheet capacity, which limits financial flexibility if operating conditions worsen.
- Technical downtrend with thin support: The stock is down 10.03% YTD and sits at just 8.6% of its 52-week range, only 2.6% above the $96.53 low. Momentum is worsening, with the 1-month decline of -8.56% steeper than the 3-month decline of -9.06%, and a break below $96.53 could trigger further selling.
CPT Technical Analysis
Camden is in a sustained downtrend, with the shares down 7.64% over the past year and 10.03% year-to-date, and the current price of $99.12 sits at just 8.6% of the 52-week range between a $96.53 low and a $119.81 high. That positioning near the bottom of the annual range signals persistent distribution rather than a healthy pullback, and the stock is now testing territory that has historically defined capitulation lows. The 52-week low of $96.53 is only 2.6% below the current price, so the margin of safety from a technical standpoint is thin, and a decisive break below that level would likely invite further momentum-driven selling. Momentum is clearly negative and worsening: the 1-month change of -8.56% is steeper than the 3-month change of -9.06%, indicating the decline has accelerated rather than stabilized. The 6-month change of +1.81% shows the stock was higher earlier in the year, so the recent weakness represents a full round-trip and a failed recovery attempt rather than a simple continuation of a long slide. Relative strength confirms the underperformance, with the stock lagging SPY by 7.60 percentage points over one month and 22.65 points over one year, while the short ratio of 4.91 suggests bears are not yet being squeezed. The 52-week low at $96.53 is the critical support to watch, and a breakdown below it would signal a new leg lower, while resistance at the $119.81 high is 20.9% above the current price and would require a major sentiment shift to challenge. With a beta of 0.782, Camden is roughly 22% less volatile than the broader market, which softens the severity of drawdowns but also means it will likely underperform in sharp risk-on rallies. The maximum drawdown of -15.7% over the period is consistent with a defensive REIT in a rate-sensitive downturn, and position sizing should account for the fact that the low beta offers limited downside cushion when sector-specific headwinds dominate.
Beta
0.78
0.78x market volatility
Max Drawdown
-16.0%
Largest decline past year
52-Week Range
$97-$120
Price range past year
Annual Return
-8.2%
Cumulative gain past year
| Period | CPT Return | S&P 500 |
|---|---|---|
| 1m | -7.7% | +1.0% |
| 3m | -10.7% | +5.5% |
| 6m | +1.7% | +19.9% |
| 1y | -8.2% | +16.0% |
| ytd | -9.9% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CPT Fundamental Analysis
Camden's revenue trajectory has flattened to a near-standstill, with Q1 2026 revenue of $390.87 million growing just 0.08% year-over-year versus $390.57 million in Q1 2025. The multi-quarter trend shows revenue essentially locked in a $390-397 million band, with Q2 2025 at $396.51 million, Q3 2025 at $395.68 million, and Q4 2025 at $390.79 million, indicating that rent growth has stalled and occupancy gains are no longer offsetting concessions. The only disclosed segment, management fee revenue of $1.84 million, is immaterial to the consolidated top line, so the investment case rests entirely on same-store multifamily performance. This stagnation is the core fundamental problem: without revenue growth, earnings growth must come from margin expansion or capital allocation, both of which have limited runway. Profitability remains positive but is deteriorating at the operating line, with Q1 2026 net income of $42.45 million translating to a 10.86% net margin, down sharply from the 39.93% net margin in Q4 2025 and the 27.53% in Q3 2025. The quarterly gross margin of -15.38% in Q1 2026 is an artifact of how cost of revenue is classified in that period, but the trailing gross margin of 61.41% and operating margin of 18.36% are more representative of the underlying business, and both are respectable for a residential REIT. The concerning signal is that Q1 2026 operating income of $75.18 million was essentially flat versus $75.11 million in Q1 2025, meaning the company is running hard to stand still while interest expense of $37.36 million consumes a rising share of earnings. The balance sheet is moderately levered with a debt-to-equity ratio of 0.894 and a debt ratio of 0.472, while the current ratio of 0.101 reflects the REIT's normal practice of holding minimal current assets against current liabilities. Free cash flow tells a more encouraging story, with TTM free cash flow of $714.01 million and Q4 2025 free cash flow of $195.84 million, though Q1 2026 free cash flow turned negative at -$41.82 million due to $189.92 million of capital expenditure and $262.83 million of stock repurchases. The ROE of 8.81% and ROA of 1.87% are modest but positive, and the dividend payout ratio of 119.89% against a 3.86% dividend yield is a red flag that the distribution is not fully covered by earnings, even if cash flow coverage is better. The company is funding buybacks and dividends partly through balance sheet capacity rather than pure internal generation, which limits financial flexibility if operating conditions worsen.
Quarterly Revenue
$390869000.0B
2026-03
Revenue YoY Growth
+0.1%
YoY Comparison
Gross Margin
-15.4%
Latest Quarter
Free Cash Flow
$714013000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CPT Overvalued?
Because Camden's trailing net income is positive, the PE ratio is the appropriate primary metric, and the trailing PE of 31.10x against a forward PE of 90.94x implies the market expects earnings to decline sharply rather than grow, a highly unusual and bearish signal. The forward multiple being nearly three times the trailing multiple suggests consensus estimates are modeling a significant earnings compression, likely from higher interest costs, lower transaction gains, or reduced operating leverage. This gap is the single most important valuation datapoint in the analysis because it means the stock is not cheap on forward earnings despite appearing moderately valued on trailing results. Relative to the residential REIT sector, Camden's trailing PE of 31.10x and price-to-book of 2.73x represent a premium to the typical REIT, which often trades between 15x and 25x earnings and 1.5x to 2.5x book, though the sector comparison is complicated by the wide dispersion in REIT earnings quality. The PS ratio of 7.58x and EV/EBITDA of 13.77x are more informative for a capital-intensive REIT, and the EV/EBITDA multiple is elevated relative to the 10x-12x range that typically signals value in multifamily. The PEG ratio of 0.229 is distorted by the near-zero earnings base and should not be relied upon, while the dividend yield of 3.86% is above the sector average and provides some valuation support. Historically, Camden's PE has ranged from roughly 12x in Q4 2023 to over 84x in Q1 2025, and the current 31.10x sits in the middle of that band but well above the low end, while the price-to-book of 2.73x is near the upper end of its historical 2.1x-2.9x range. The stock is therefore not at a historical valuation trough despite being near a 52-week price low, which suggests the market is pricing in earnings deterioration rather than offering a clean value opportunity.
PE
31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~127x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.8x
Enterprise Value Multiple
Investment Risk Disclosure
Camden's financial risks are mounting as revenue growth has stalled at 0.08% YoY in Q1 2026, with the top line locked in a $390-397 million band for five consecutive quarters. The dividend payout ratio of 119.89% against a 3.86% yield means the distribution is not covered by earnings, and Q1 2026 free cash flow turned negative at -$41.82 million due to $189.92 million of capex and $262.83 million of buybacks. Interest expense of $37.36 million consumes a rising share of operating income, which was essentially flat at $75.18 million versus $75.11 million a year earlier, leaving little margin for error if operating conditions deteriorate. The debt-to-equity ratio of 0.894 and current ratio of 0.101 reflect moderate leverage and minimal liquidity, limiting financial flexibility.
Market and competitive risks are significant given the stock's premium valuation and negative momentum. The trailing PE of 31.10x and price-to-book of 2.73x are above the typical residential REIT range of 15-25x earnings and 1.5-2.5x book, while the EV/EBITDA of 13.77x exceeds the 10-12x range that typically signals value in multifamily. The forward PE of 90.94x implies the market expects earnings to decline sharply, and any further compression could drive the stock lower. With a beta of 0.782, Camden is less volatile than the market but will likely underperform in risk-on rallies, and the stock has lagged SPY by 22.65 percentage points over one year. The short ratio of 4.91 suggests bears are not yet squeezed, leaving room for further downside if sentiment worsens.
The worst-case scenario involves a continued supply overhang in Sun Belt markets, persistent revenue stagnation, and a breakdown below the 52-week low of $96.53. If the stock breaks that support, momentum-driven selling could push it toward the analyst low target of $105.00, though that is above the current price; a more realistic downside is a retest of the 52-week low at $96.53, representing a 2.6% decline from the current $99.12. In a severe scenario where the dividend is cut or earnings collapse further, the stock could fall to the $85-90 range, implying a 9-14% loss from current levels. The maximum drawdown of -15.7% over the past period provides a historical reference for downside severity in a rate-sensitive downturn.
FAQ
The most severe risk is a dividend cut, as the payout ratio of 119.89% exceeds earnings and Q1 2026 free cash flow was negative at -$41.82 million. Second, revenue growth has stalled at 0.08% YoY, and if multifamily supply remains elevated, same-store revenue could decline, pressuring earnings further. Third, the stock is in a technical downtrend, down 10.03% YTD and just 2.6% above the 52-week low of $96.53; a breakdown could trigger momentum-driven selling. Fourth, the forward PE of 90.94x implies consensus expects a sharp earnings decline, and if estimates are revised lower, the stock could face further multiple compression. These risks are ranked from most to least severe, with the dividend and revenue stagnation being the primary concerns.
The 12-month forecast has three scenarios: a bull case with 25% probability targeting $120-132, a base case with 55% probability targeting $105-117, and a bear case with 20% probability targeting $85-96. The base case is most likely, assuming revenue growth remains sluggish at 0-1% YoY and the stock trades in a range between the 52-week low and the analyst average target of $116.60. The key assumption behind the base case is that the multifamily supply wave peaks in 2026 without a severe recession, allowing Camden to maintain its dividend and gradually improve cash flow coverage. The bull case requires accelerating rent growth and multiple expansion, while the bear case assumes a dividend cut or a breakdown below $96.53.
CPT appears fairly valued to slightly overvalued on trailing metrics, with a trailing PE of 31.10x and price-to-book of 2.73x above the typical residential REIT range of 15-25x earnings and 1.5-2.5x book. The EV/EBITDA of 13.77x exceeds the 10-12x range that typically signals value in multifamily, and the forward PE of 90.94x implies the market expects a sharp earnings decline. However, the 3.86% dividend yield is above the sector average and provides some valuation support, and the stock is near its 52-week low, which may already reflect much of the bad news. The market is pricing in earnings deterioration rather than offering a clean value opportunity, so the stock is not cheap on forward earnings despite the low price.
CPT is a hold rather than a strong buy at current levels, with the stock at $99.12 near its 52-week low of $96.53 and analyst targets implying 17.6% upside to $116.60. The 3.86% dividend yield and low beta of 0.782 make it attractive for income-focused investors, but revenue growth has stalled at 0.08% YoY and the forward PE of 90.94x signals expected earnings compression. The biggest downside risk is a breakdown below $96.53, which could trigger further selling toward $85-90. For long-term income investors with a 2-3 year horizon, the risk/reward is balanced, but for short-term traders, the negative momentum and lack of catalysts make it a poor entry point.
CPT is better suited for long-term investment, with a suggested minimum holding period of 2-3 years to allow for a multifamily supply-demand inflection and potential multiple expansion. The stock's low beta of 0.782 and 3.86% dividend yield make it a defensive income play, but the negative momentum and 10.03% YTD decline make it a poor short-term trading candidate. Earnings visibility is low given the 0.08% revenue growth and 119.89% payout ratio, so short-term traders face significant downside risk if the stock breaks below $96.53. Long-term investors can collect the dividend while waiting for rent growth to recover, but they should monitor the payout ratio and free cash flow closely.